In a mixed diabetic and non-diabetic cohort of patients with coronary heart disease, higher FGF-23 predicted CV outcomes in the diabetic but not in the non-diabetic patients suggesting potential biological differences in the FGF-23 response between patients with and without diabetes[23]. The gene discussed is FGF23; the disease is coronary artery disorder.